These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Biochemical effects in patients with calcium oxalate stone disease during combined treatment with bendroflumethiazide and magnesium oxide. Ahlstrand C; Tiselius HG Br J Urol; 1984 Apr; 56(2):125-30. PubMed ID: 6498431 [TBL] [Abstract][Full Text] [Related]
30. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY; Sakhaee K; Fuller CJ Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957 [TBL] [Abstract][Full Text] [Related]
31. [Urate nephrolithiasis. Cause of consequence?]. Mertz DP Fortschr Med; 1976 Jul; 94(20-21):1160-4. PubMed ID: 955552 [TBL] [Abstract][Full Text] [Related]
32. Long-term treatment of calcium nephrolithiasis with potassium citrate. Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044 [TBL] [Abstract][Full Text] [Related]
33. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers. Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420 [TBL] [Abstract][Full Text] [Related]
34. Who makes uric acid stones and why--observations from a renal stones clinic. Stansbridge EM; Griffin DG; Walker V J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727 [TBL] [Abstract][Full Text] [Related]
35. Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers. Drach GW J Urol; 1976 Sep; 116(3):338-40. PubMed ID: 957503 [TBL] [Abstract][Full Text] [Related]
36. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798 [TBL] [Abstract][Full Text] [Related]
37. Biochemical and dietary factors of uric acid stone formation. Trinchieri A; Montanari E Urolithiasis; 2018 Apr; 46(2):167-172. PubMed ID: 28246885 [TBL] [Abstract][Full Text] [Related]
38. Biochemical studies in calcium oxalate stone formers, with special reference to the effects of thiazide treatment. Ahlstrand C Scand J Urol Nephrol Suppl; 1984; 81():1-93. PubMed ID: 6387895 [No Abstract] [Full Text] [Related]
39. [Evaluation of uric acid transport in nephrons of patients with calcium nephrolithiasis and hyperuricosuria]. Tykarski A; Pupek-Musialik D; Posadzy-Małaczyńska A Pol Arch Med Wewn; 1993 Jul; 90(1):26-33. PubMed ID: 8234002 [TBL] [Abstract][Full Text] [Related]